Biovance 3L Ocular – Overview Sheet

Biovance 3L Ocular Product Brochure

Biovance 3L Ocular – Clinical Application Process

Biovance 3L Ocular – Clinical Application Process [VIDEO]

Biovance 3L Ocular – Pterygium Surgery Application Process

Biovance 3L Ocular – Glueless, Sutureless Pterygium Surgery [VIDEO] – Saha

Biovance 3L Ocular – Glueless, Sutureless Pterygium Surgery [VIDEO] – Diaz

Biovance 3L Ocular – Order Form

Biovance 3L Ocular – Insurance Verification Form

2025 Medicare Ocular Reimbursement Codes Flashcard

Biovance 3L Ocular –  Benchtop Study Reprint

Biovance 3L Ocular – Case Study – Anterior Membrane Dystrophy

Peer-Reviewed Article entitled “An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study”; Mao Y. et al; J Biomed Mater Res. 2022;1–17.

Peer-Reviewed Article entitled “Surgical Time and Postoperative Symptoms Study in Pterygium Excision and Amniotic Membrane Graft Using Celularity Triple Layer Dehydrated Amniotic Membrane“; Rivera-Morales P. et al; Clin Ophthal 2023:17;1967-1974. https://doi.org/10.2147/OPTH.S410452

Peer-Reviewed Article entitled “Use of an Eyelid Pressure Patch Concomitantly with a Decellularized Dehydrated Amniotic Membrane for Ocular Surface Disease Management.”; Linsey, K.; Ophthalmol Ther (2025). https://doi.org/10.1007/s40123-025-01094-2

Ophthalmology Times Article – 3-layer amniotic membrane successfully treats severe case of keratoconjunctivitis sicca

Healio Article – Biovance 3L Ocular effective in patients with chronic ocular surface disease

eyetube Video: Glueless, Sutureless Pterygium Surgery With Amniotic Membrane

Ophthalmology360 Article – Eyelid pressure patching enhances amniotic membrane therapy for corneal healing

Ophthalmology Times Article – Gaining control of persistent corneal epithelial defects using AMT and a pressure patch

Verséa is a registered trademark of Verséa Health, Inc.

©2025 Verséa Ophthalmics, Inc. All rights reserved.